Prof. Dr. VURAL TANER YILMAZ

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 68

1. Timeline and Incidence of Infectious Complications in Older Transplant Recipients During the First Year Post-Transplantation

Ayaz Ceylan Ç. M., Yılmaz V. T., Adanır H., Turhan Ö.

PATHOGENS , ss.12-23, 2024 (SCI-Expanded)

2. Can the pan-immune-inflammation value predict gram negative bloodstream infection-related 30-day mortality in solid organ transplant patients?

Ayaz Ç. M., Turhan Ö., Yılmaz V. T., Adanır H., Sezer B., Öğünç D.

BMC Infectious Diseases , cilt.24, sa.1, 2024 (SCI-Expanded)

3. Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1/PD-L1 mRNA expression in kidney transplant recipients

Ekinci N. S., YILMAZ V. T., KILINÇ Y., KOÇAK H., Darbas S., KISAOĞLU A., et al.

Clinical Transplantation , cilt.37, sa.11, 2023 (SCI-Expanded)

4. Evaluation of the effect and predictive role of vitamin D and vitamin D receptor expression in CD4 + , CD8 + , CD14 + , CD56 + cells on the development of chronic rejection and graft functions in kidney transplant patients

Vural T., YILMAZ V. T., KÖKSOY S., KISAOĞLU A., ÖZEL D., DEMİRYILMAZ İ., et al.

International Urology and Nephrology , cilt.55, sa.10, ss.2589-2598, 2023 (SCI-Expanded)

5. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.

Yilmaz V. T., Kisaoglu A., Avanaz A., Dandin O., Ozel D., Mutlu D., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.21, sa.9, ss.727-734, 2023 (SCI-Expanded)

6. The Factors Affecting Mortality After Pediatric Liver Transplantation and Long-Term Survival Outcomes: A Single Center Experience.

Avanaz A., Ünal D., Kisaoglu A., Yilmaz V. T., Moharer P. S., Demiryilmaz I., et al.

Transplantation proceedings , cilt.55, sa.5, ss.1182-1185, 2023 (SCI-Expanded)

7. Regulatory B Cells Profile in Kidney Transplant Recipients With Chronic-Active Antibody-Mediated Rejection

Guzel H. G., Yılmaz V. T., Köksoy S., Koçak H., Kısaoğlu A., Soylu M., et al.

Transplantation Proceedings , cilt.55, sa.5, ss.1140-1146, 2023 (SCI-Expanded)

8. Impact of older age on the long-term survival in living-donor liver transplantation: A propensity score matching analysis.

Avanaz A., Doğru V., Kisaoglu A., Yilmaz V. T., Ünal D., Demiryilmaz I., et al.

Asian journal of surgery , cilt.45, sa.11, ss.2239-2245, 2022 (SCI-Expanded)

9. Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience

Yilmaz V. T., Dandin O., Kisaoglu A., Avanaz A., Kamaci D., Toru H. S., et al.

Transplantation Proceedings , cilt.54, sa.7, ss.1809-1815, 2022 (SCI-Expanded)

10. A UFLC-MS/MS Method for the Simultaneous Analysis of Urinary Podocin and Podocalyxin in Patients with Nephrotic Syndrome.

Karatoy Erdem B., Özcan M., Yılmaz V. T., Akkaya B., Çetinkaya R., Ersoy F., et al.

Laboratory medicine , cilt.53, sa.3, ss.246-254, 2022 (SCI-Expanded)

11. Comparison of tomographic kidney volumes measured by semi-automatic segmentation method with scintigraphic split renal function in predicting posttransplant kidney functions.

Yılmaz V. T., Tulum G., Dandin Ö., Kısaoğlu A., Cüce F., Ergin T., et al.

Clinical physiology and functional imaging , 2022 (SCI-Expanded)

12. The relationship between COVID-19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors

ERTOSUN M. G., ÖZKAN Ö., Darbas S., ÖZEL ERKAN D., BİLGE U., Ekinci N. S., et al.

CLINICAL TRANSPLANTATION , cilt.36, sa.2, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Safety and Threshold Analysis of Preoperative Platelets in Right Lobe Living Donors for Liver Transplantation

KISAOĞLU A., DOĞRU V., YILMAZ V. T., DEMİRYILMAZ İ., AVANAZ A., SARIKAYA S. M., et al.

JOURNAL OF GASTROINTESTINAL SURGERY , cilt.26, sa.1, ss.77-85, 2022 (SCI-Expanded)

14. Association Between Graft Function and Urine CXCL10 and Acylcarnitines Levels in Kidney Transplant Recipients

Başak Oktay S., Akbaş S. H., Yilmaz V. T., Özen Küçükçetin İ., Toru H. S., Yücel S. G.

LABORATORY MEDICINE , cilt.53, sa.1, ss.78-84, 2022 (SCI-Expanded)

15. Effect of post-perfusion hyperoxemia on early graft function in renal transplant recipients: a retrospective observational cohort study

DİNÇ B., YILMAZ V. T., AYCAN İ. Ö., KISAOĞLU A., DANDİN Ö., AYDINLI B., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.190, sa.4, ss.1539-1545, 2021 (SCI-Expanded)

16. Serum Levels of S100 beta, Neuron-Specific Enolase, Glial Fibrillary Acidic Protein in Kidney Transplant Recipients and Donors: A Prospective Cohort Study

Dinc B., Yılmaz V. T., Aslan M., Aycan İ. Ö., Kiraz N., Kisaoglu A., et al.

TRANSPLANTATION PROCEEDINGS , cilt.53, sa.7, ss.2227-2233, 2021 (SCI-Expanded)

17. The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients

Yazısız V., Yılmaz V. T., Uçar İ., Dandin Ö., Aslan B., Erbasan F., et al.

ARCHIVES OF RHEUMATOLOGY , cilt.36, sa.3, ss.366-374, 2021 (SCI-Expanded)

18. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3 ' UTR 14 bp polymorphism and sHLA-G

Darbas S., YILMAZ V. T., KOÇAK H., KISAOĞLU A., DEMİRYILMAZ İ., AYDINLI B., et al.

GENE , cilt.790, 2021 (SCI-Expanded)

19. A Single-Center Experience in Portal Flow Augmentation in Liver Transplantation With Prior Large Spontaneous Splenorenal Shunt

Kısaoğlu A., Dandin Ö., Demiryılmaz İ., Dinç B., Adanır H., Yılmaz V. T., et al.

TRANSPLANTATION PROCEEDINGS , cilt.53, sa.1, ss.54-64, 2021 (SCI-Expanded)

20. Tacrolimus-Associated Pure Red Cell Aplasia in a Patient With Renal Transplant

YÜCEL O. K., ALEMDAR M. S., AKKAYA B., KOÇAK H., SÜLEYMANLAR G., YILMAZ V. T.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , cilt.3, ss.25-29, 2020 (SCI-Expanded)

21. Living donor kidney transplantation after desensitization in cross-match positive high sensitized patients.

Yilmaz V. T., Kisaoglu A., Dandin O., Demiryilmaz I., Koksoy S., Aydinli B., et al.

Hippokratia , cilt.24, sa.4, ss.182-190, 2020 (SCI-Expanded)

22. Comparison of Clinical Outcomes in Hepatitis B Virus-Positive and -Negative Renal Transplant Recipients

YILMAZ V. T., ÇETİNKAYA R., Akbas H., ÖZDEM S., ÜLGER B. V., Erbis H., et al.

INTERNATIONAL SURGERY , cilt.104, sa.9-10, ss.423-430, 2019 (SCI-Expanded)

23. THE ROLE OF VITAMIN D AND VITAMIN D RECEPTOR LEVELS IN DEVELOPMENT OF CHRONIC REJECTION IN KIDNEY TRANSPLANT RECIPIENTS

Vural T., KÖKSOY S., YILMAZ V. T., KOÇAK H., ERSOY F. F., SÜLEYMANLAR G.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.34, sa.1, ss.598, 2019 (SCI-Expanded)

24. Cardiovascular and neurological complications in kidney transplant recipients: a focused appraisal of symptoms

DOĞAN U., YAPRAK M., APAYDIN DOĞAN E., ONAÇ M., YILMAZ V. T., AYDINLI B.

TRANSPLANTATION PROCEEDINGS , cilt.51, ss.1101-1107, 2019 (SCI-Expanded)

25. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey

Yalin S. F., EREN N., Sinangil A., YILMAZ V. T., Tatar E., Ucarf A. R., et al.

NEPHRON , cilt.142, sa.1, ss.26-33, 2019 (SCI-Expanded)

26. Renoportal anastomosis in living donor liver transplantation

KISAOĞLU A., DEMİRYILMAZ İ., DANDİN Ö., YILMAZ V. C., AYDINLI B.

HIPPOKRATIA , cilt.23, sa.3, ss.140-142, 2019 (SCI-Expanded)

27. Factors influencing disease recurrence and graft survival in patients who developed end stage renal disease due to focal segmental glomerulosclerosis and underwent renal transplantation

YILMAZ V. T., KOÇAK H., ÇETİNKAYA R., ULGER B. V., SÜLEYMANLAR G.

INTERNATIONAL SURGERY , cilt.103, ss.47-55, 2018 (SCI-Expanded)

28. Fabry Disease Prevalence in Kidney Transplant Patients: A Multicenter Study

YALIN S., EREN N., SİNANGİL A., UÇAR A., YILMAZ V. T., GURKAN A., et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , sa.28, ss.841, 2017 (SCI-Expanded)

29. Fabry Disease Prevalence in Kidney Transplant Patients: A Multicenter Study

YILMAZ V. T.

TRANSPLANT INTERNATIONAL , sa.2, ss.841, 2017 (SCI-Expanded)

30. SUCCESSFUL RENAL TRANSPLANTATION AFTER DESENSITIZATION IN PATIENTS WITH SENSITIZED END STAGE RENAL DISEASE

YILMAZ V. T., KOÇAK H., KISAOĞLU A., KÖKSOY S., ÇETİNKAYA R., SÜLEYMANLAR G., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.318, 2017 (SCI-Expanded)

31. PREDICTIVE ROLES OF PROINFLAMMATORY CYTOKINES IN ACUTE RENAL ALLOGRAFT REJECTION

YILMAZ V. T., Davran F., SÜLEYMANLAR G., AKBAS H.

TRANSPLANT INTERNATIONAL , cilt.30, ss.373, 2017 (SCI-Expanded)

32. OUR ONE-YEAR EXPERIENCE FOR LIVER TRANSPLANTION

KISAOĞLU A., MUTLU F., DANDİN Ö., YAPRAK M., DİNÇ B., YILMAZ V. T., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.464, 2017 (SCI-Expanded)

33. ELECTROCARDIOGRAPHY CHANGES DURING REPERFUSION IN LIVING DONOR KIDNEY TRANSPLANTATIONS

DİNÇ B., HADİMİOĞLU N., ERTUĞ Z., KISAOĞLU A., DANDIN Ö., YILMAZ V. T., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.502-503, 2017 (SCI-Expanded)

34. Consideration of difficulties and exit strategies in a case of face allotransplantation resulting in failure

ÖZKAN Ö., ÖZKAN Ö., DOĞAN U., YILMAZ V. T., UYSAL H., ÜNDAR L., et al.

MICROSURGERY , cilt.37, sa.6, ss.661-668, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

35. ACUTE AND CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: PROGNOSIS AND TREATMENT

YILMAZ V. T., KOÇAK H., SÜLEYMANLAR G., ÇETİNKAYA R., AKKAYA B., AKBAS H., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.527, 2017 (SCI-Expanded)

36. THE EFFECT ON GRAFT FUNCTION AND SURVIVAL OF BK VIRUS VIREMIA AND NEPHROPATHY IN RENAL TRANSPLANT PATIENTS

YILMAZ V. T., KOÇAK H., SÜLEYMANLAR G., ÇETİNKAYA R., KISAOĞLU A., ÇOLAK D., et al.

TRANSPLANT INTERNATIONAL , cilt.30, ss.201, 2017 (SCI-Expanded)

37. COMPARISON OF MTORIS AND CALCINEURIN INHIBITORS IN LOW-IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS

YILMAZ V. T., KOÇAK H., SÜLEYMANLAR G., ÇETİNKAYA R., KISAOĞLU A., AYDINLI B.

TRANSPLANT INTERNATIONAL , cilt.30, ss.254, 2017 (SCI-Expanded)

38. SHOULD KIDNEY TRANSPLANTATION BE DONE FROM ELDERLY DONORS?

YILMAZ V. T., KOÇAK H., SÜLEYMANLAR G., ÇETİNKAYA R., KISAOĞLU A., AYDINLI B.

TRANSPLANT INTERNATIONAL , cilt.30, ss.170, 2017 (SCI-Expanded)

39. The relationship between vitamin D status and graft function in renal transplant recipients

KARATOY ERDEM B., YILMAZ V. T., SÜLEYMANLAR G., ÖZCAN F., BAYKAL A., AKBAŞ S. H.

FEBS JOURNAL , sa.1, ss.128, 2017 (SCI-Expanded)

40. Comparison of clinical outcomes in hepatitis B virus positive and negative renal transplant recipients

YILMAZ V. T., ÇETİNKAYA R., AKBAŞ S. H., ÖZDEM S., ULGER B. V., ERBİŞ H., et al.

INTERNATIONAL SURGERY , cilt.102, ss.126-132, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Left ventricle ejection fraction may predict mortality in renal transplant Patients

Özkul F., Arik M. K., ERBİŞ H., Akbas A., YILMAZ V. T., Barutcu A., et al.

RENAL FAILURE , cilt.13, ss.1-4, 2016 (SCI-Expanded)

42. Effect of age on the outcome of renal transplantation: A single-center experience

Ozkul F., Erbis H., YILMAZ V. T., KOÇAK H., Osmanoglu I. A., Dinckan A.

PAKISTAN JOURNAL OF MEDICAL SCIENCES , cilt.32, sa.4, ss.827-830, 2016 (SCI-Expanded)

43. Association of interleukin 18-607A/C and -137C/G polymorphisms with oxidative stress in renal transplant recipients.

Davran F., Yilmaz V. T., Erdem B., Gultekin M., Suleymanlar G., Akbas H.

Renal failure , cilt.38, ss.717-22, 2016 (SCI-Expanded)

44. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].

KıLıNÇKAYA D. H., MUTLU E., KÖKSOY S., YILMAZ V. T., KOÇAK H., ÇOLAK D., et al.

MIKROBIYOLOJI BULTENI , cilt.50, sa.2, ss.224-35, 2016 (SCI-Expanded)

45. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors

YILMAZ V. T., Aliosmanoglu I., Erbis H., Ulger B. V., ÇETİNKAYA R., SÜLEYMANLAR G., et al.

TRANSPLANT INFECTIOUS DISEASE , cilt.18, sa.1, ss.55-62, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Delayed graft function in living-donor renal transplantation: a single-center experience with 1537 patients

Ozkul F., Erbis H., YILMAZ V. T., Ozturk B., KOÇAK H., Osmanoglu I. A., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.3, ss.6716-6719, 2016 (SCI-Expanded)

47. Therapy Modalities for Antibody Mediated Rejection in Renal Transplant Patients

YILMAZ V. T., SÜLEYMANLAR G., KÖKSOY S., ÜLGER B. V., ÖZDEM S., AKBAŞ S. H., et al.

JOURNAL OF INVESTIGATIVE SURGERY , cilt.29, sa.5, ss.282-288, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

48. RECONSTRUCTION OF SEGMENT 5 AND 8 VEINS IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION: AKDENIZ UNIVERSITY EXPERIENCE

Aliosmanoglu I., ÜLGER B. V., Erbis H., Tuna Y., Ozturk B., YILMAZ V. T., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.373, 2015 (SCI-Expanded)

49. LIVING DONOR LIVER TRANSPLANTATION FOR CLASSICAL MAPLE SYRUP URINE DISEASE: CASE REPORT

Aliosmanoglu I., Erbis H., SOYUÇEN E., Ozturk B., YILMAZ V. T., Dinckan A.

TRANSPLANT INTERNATIONAL , cilt.28, ss.461, 2015 (SCI-Expanded)

50. AN UNUSUAL CAUSE OF BILIARY OBSTRUCTION AFTER LIVER TRANSPLANTATION: FASCIOLA HEPATICA

Erbis H., ÜLGER B. V., Aliosmanoglu I., Ozturk B., YILMAZ V. T., Dinckan A.

TRANSPLANT INTERNATIONAL , cilt.28, ss.697, 2015 (SCI-Expanded)

51. RETRO-URETERAL INTERNAL HERNIA AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: A VERY RARE CASE

ÜLGER B. V., Aliosmanoglu I., Erbis H., YILMAZ V. T., Ozturk B., Calli I., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.806, 2015 (SCI-Expanded)

52. HEPATOPULMONARY SYNDROME RELATED PORTAL HYPERTENSION

Erbis H., Calli I., Mutlu F., ÜLGER B. V., Tuna Y., Ozturk B., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.836, 2015 (SCI-Expanded)

53. THE ASSESMENT OF LONG TERM OUTCOMES IN HBSAG NEGATIVE RENAL TRANSPLANT RECIPIENTS WHO WERE TRANSPLANTED FROM HBSAG POSITIVE DONORS

YILMAZ V. T., ÜLGER B. V., Aliosmanoglu I., Erbis H., Tuna Y., AKBAŞ S. H., et al.

TRANSPLANT INTERNATIONAL , cilt.28, ss.233, 2015 (SCI-Expanded)

54. THE THYROID CANCER INCIDENCE IN AN ENDEMIC GOITER REGION AND THE RELATIONSHIP OF THYROID CANCER WITH NODULE DIAMETER

Ay N., Oz A. B., Alp V., Bahadir M. V., YILMAZ V. T., Dinc B., et al.

ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.11, sa.4, ss.444-448, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Nebivolol Ameliorates Hepatic Ischemia/Reperfusion Injury on Liver But Not on Distant Organs

ÜLGER B. V., Erbis H., Turkcu G., Ekinci A., Turkoglu M. A., Ekinci C., et al.

JOURNAL OF INVESTIGATIVE SURGERY , cilt.28, sa.5, ss.245-252, 2015 (SCI-Expanded)

56. The Thyroid Cancer Incidence in an Endemic Goiter Region and the Relationship of Thyroid Cancer with Nodule Diameter

AY N., ÖZ A., ALP V., BAHADIR M., YILMAZ V. T., DİNÇ B., et al.

ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.11, sa.4, ss.444-448, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

57. Assessment of Long-Term Outcomes in Hbs Ag-Negative Renal Transplant Recipients Transplanted from Hbs Ag-Positive Donors

YILMAZ V. T., Ulger B. V., Aliosmanoglu I., Erbis H., Tuna Y., AKBAS H., et al.

ANNALS OF TRANSPLANTATION , cilt.20, ss.390-396, 2015 (SCI-Expanded)

58. The Association of Serum Free Light Chain Levels with Markers of Renal Function

KARATOY ERDEM B., DAVRAN F., YILMAZ V. T., ÇETİNKAYA R., AKBAŞ S. H.

RENAL FAILURE , cilt.37, sa.6, ss.1057-1060, 2015 (SCI-Expanded)

59. Nebivolol ameliorates hepatic ischemia reperfusion injury on liver but not on distant organs

Ulger B. V., ERBİŞ H., Türkçü G., Ekinci A., TÜRKOĞLU M. A., Ekinci C., et al.

JOURNAL OF INVESTIGATIVE SURGERY , cilt.28, ss.245-252, 2015 (SCI-Expanded)

60. The association of serum-free light-chain levels with markers of renal function

Erdem B. K., Davran F., YILMAZ V. T., ÇETİNKAYA R., Akbas H.

RENAL FAILURE , cilt.37, sa.6, ss.1057-1060, 2015 (SCI-Expanded)

61. Is Klotho F352V Polymorphism the Missing Piece of the Bone Loss Puzzle in Renal Transplant Recipients?

ÖZDEM S., YILMAZ V. T., ÖZDEM S. S., DÖNMEZ L., ÇETİNKAYA R., SÜLEYMANLAR G., et al.

PHARMACOLOGY , cilt.95, sa.5-6, ss.271-278, 2015 (SCI-Expanded)

62. Association between graft function and serum TNF-alpha, TNFR1 and TNFR2 levels in patients with kidney transplantation

BUDAK D., YILMAZ V. T., AKBAS H., SÜLEYMANLAR G., Yucel G.

RENAL FAILURE , cilt.37, sa.5, ss.871-876, 2015 (SCI-Expanded)

63. Acute renal failure due to uterine prolapse: a case report

Yilmaz V. T., Avci A. B., Şahin A. F., Bozkurt H., Doğan F.

RENAL FAILURE , cilt.35, sa.6, ss.879-884, 2013 (SCI-Expanded)

64. The effect of kidney diseases on survival in liver transplant patients

SÜLEYMANLAR İ., YILMAZ V. T., KOÇAK H., Dinckan A., Gurkan A., Ersoy F., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.43, sa.3, ss.827-833, 2011 (SCI-Expanded)

65. Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient

YILMAZ V. T., KOÇAK H., AVCI A. B., SALİM O., ERSOY F. F., SÜLEYMANLAR G.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.43, sa.2, ss.581-588, 2011 (SCI-Expanded)

66. Relationship of increased serum brain natriuretic peptide levels with hepatic failure, portal hypertension and treatment in patients with cirrhosis

YILMAZ V. T., Eken C., Avci A. B., Duman A., Tuna Y., Akin M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.4, ss.381-386, 2010 (SCI-Expanded)

67. Chyluria and Delayed Graft Function in Early Posttransplant Period in a Renal Transplant Patient

YILMAZ V. T., Dinc B., Ay N., Karayalcin B., Kilicarslan B., Gurkan A., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.340, sa.2, ss.169-172, 2010 (SCI-Expanded)

68. The safety of hem-o-lock clips at donor nephrectomies

AY N., DINC B., Dinckan A., YILMAZ V. T., Erdogan O., GURKAN A.

ANNALS OF TRANSPLANTATION , cilt.15, sa.1, ss.36-39, 2010 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 52

1. Determination of HLA Tissue Type According to the Etiology of Patients with Chronic Renal Failure

KARAKUŞ B., UÇAR F., YILMAZ V. T., KILINÇ Y., KOÇAK H., ARAS Ş., et al.

Medeniyet medical journal , cilt.39, sa.4, ss.243-253, 2024 (Hakemli Dergi)

2. Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience

Avanaz A., Adanir H., Kisaoglu A., Yilmaz V. T., Avanaz E., Dinc B., et al.

Eurasian Journal of Medicine , cilt.55, sa.3, ss.254-258, 2023 (ESCI)

3. Successful Kidney Transplantation in a Patient with Marfan’s Syndrome with a History of Aortic Dissection Operation and a Dissection Flap Up to the Iliac Bifurcation Level

Yilmaz V. T., Kisaoglu A., Avanaz A., Demiryilmaz I., Ucar F., Aydinli B., et al.

Turkish Journal of Nephrology , cilt.32, sa.1, ss.98-101, 2023 (ESCI)

4. Diagnosis and treatment of splenic artery steal syndrome after liver transplantation

AVANAZ A., AVANAZ E., KISAOĞLU A., YILMAZ V. T., DEMİRYILMAZ İ., AYDINLI B.

SURGICAL PRACTICE , cilt.26, sa.4, ss.273-275, 2022 (ESCI)

5. Diagnosis and Treatment of Splenic Artery Steal Syndrome After Liver Transplantation

AVANAZ A., AVANAZ E., KISAOĞLU A., YILMAZ V. T., DEMİRYILMAZ İ., AYDINLI B.

Surgical Practice , 2021 (ESCI)

6. Vitamin D Receptor Contents and Receptor Express i on Rates of CD4 + a nd C D 8 + T Lymphocytes i n Renal Transplant Recipients

EDEBALİ S. U., KÖKSOY S., YILMAZ V. T., ÖZDEM S., YILMAZ F., SÖZEL H., et al.

Osmangazi Tıp Dergisi , 2021 (Hakemli Dergi)

7. A Prospective Evaluation of Vascular Calcification Markers in Renal Transplantation

Karatoy Erdem B., Yılmaz V. T., Süleymanlar G., Dinçkan A., Akbaş S. H.

TÜRK KLİNİK BİYOKİMYA DERGİSİ , cilt.18, sa.3, ss.121-128, 2020 (Hakemli Dergi)

8. Renal Transplantasyonda Vasküler Kalsifikasyon Belirteçlerinin Prospektif Değerlendirilmesi

KARATOY ERDEM B., YILMAZ V. T., SÜLEYMANLAR G., DİNÇKAN A., AKBAŞ S. H.

Türk Klinik Biyokimya Dergisi , cilt.18, sa.3, ss.121-128, 2020 (Hakemli Dergi)

9. Everolimus Toxicity in a Kidney Transplant Recipient Treated with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Chronic Hepatitis C

AKIN M., Buldukoglu O. C., ADANIR H., Yalcinkaya T., YILMAZ V. T., YILDIRIM B., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.29, sa.1, ss.82-83, 2020 (ESCI) Sürdürülebilir Kalkınma

10. Transplantasyon Sonrası Dönemde De-Novo Donör Spesifik HLA Antikorlarının Takibi Ve Klinik Sonuçları: Tek Merkez Deneyimi

YILMAZ V. T.

Akdeniz Tıp Dergisi , 2019 (Hakemli Dergi)

11. Romatizmal hastalığı olan böbrek transplantalıcılarında biyolojik tedavilerin kullanımıÜç olgu serisi ile beraber literatürün gözdengeçirilmesi

BAKIRCI s., YAZISIZ V., YILMAZ V. T., KOÇAK H., GAYRET İ., DİNÇKAN A., et al.

ULUSAL ROMATOLOJİ DERGİSİ , cilt.11, ss.157-160, 2019 (Hakemli Dergi)

12. Assessment of Vascular Calcification in Renal Transplant Recipients

ERDEM B. K., YILMAZ V. T., SÜLEYMANLAR G., AKBAŞ S. H.

International Journal of Medical Biochemistry , 2018 (Hakemli Dergi)

13. The relationship between vitamin D status and graft function in renal transplant recipients

KARATOY ERDEM B., YILMAZ V. T., BAYKAL ATAMAN A., SÜLEYMANLAR G., AKBAŞ S. H.

International Journal of Medical Biochemistry , cilt.1, sa.1, ss.1-5, 2018 (Hakemli Dergi)

14. RENAL TRANSPLANT ALICILARINDA AKUT VE KRONİK AKTİF ANTİKOR ARACILI REJEKSİYONLAR PROGNOZ VE TEDAVİ

YILMAZ V. T., SÜLEYMANLAR G., ERSOY F. F., ÇETİNKAYA R., SARI F., AKBAŞ S. H., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

15. YAŞLI DONÖRLERDEN BÖBREK NAKLİ YAPILMALI MI?

YILMAZ V. T., SÜLEYMANLAR G., ERSOY F. F., ÇETİNKAYA R., SARI F., AYDINLI B., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

16. BÖBREK NAKLİ ALICILARINDA D VİTAMİNİ İLE GREFT FONKSİYONLARI ARASINDAKİ İLİŞKİ

ERDEM B. K., YILMAZ V. T., SÜLEYMANLAR G., ÖZCAN F., ATAMAN A. B., AKBAŞ S. H.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

17. RENAL TRANSPLANT ALICILARINDA KALSİNÖRİN VE MTOR İNHİBİTÖRLERİNİN FARKLI KOMBİNASYONLARININ KARŞILAŞTIRILMASI

YILMAZ V. T., AYDINLI B., SÜLEYMANLAR G., ERSOY F. F., ÇETİNKAYA R., SARI F., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

18. RENAL TRANSPLANT HASTALARDA BK VİRÜS VİREMİSİ VE NEFROPATİSİ

YILMAZ V. T., ERSOY F. F., ÇETİNKAYA R., SARI F., ÇOLAK D., AKBAŞ S. H., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

19. DESENSİTİZASYON VE BÖBREK NAKLİ YAPILMALI MI?, YAPILMAMALI MI?

YILMAZ V. T., ÇETİNKAYA R., SÜLEYMANLAR G., ERSOY F. F., SARI F., KÖKSOY S., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

20. DÜŞÜK İMMÜNOLOJİK RİSK GRUBUNDAKİ RENAL TRANSPLANT ALICILARINDA MTOR VE KALSİNÖRİN İNHİBİTÖRLERİNİN KARŞILAŞTIRILMASI

YILMAZ V. T., SARI F., ÇETİNKAYA R., ERSOY F. F., AYDINLI B., SÜLEYMANLAR G., et al.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , 2017 (ESCI)

21. Karaciğer Nakli Tecrübemiz: Bir Yıllık Tek Merkez Çalışması

KISAOĞLU A., MUTLU F., DANDİN Ö., YAPRAK M., DİNÇ B., YILMAZ V. T., et al.

Akdeniz Tıp Dergisi , cilt.3, sa.3, ss.159-164, 2017 (Hakemli Dergi)

22. Karaciğer Nakli Tecrübemiz: Bir Yıllık Tek Merkez Çalışması. Our Liver Transplantation Experience: A One-Year Single Center Study

KISAOĞLU A., MUTLU F., Dandin Ö., YAPRAK M., DİNÇ B., YILMAZ V. T., et al.

AKDENİZ TIP DERGİSİ , sa.3, ss.159-164, 2017 (Hakemli Dergi)

23. New-Onset Diabetes Mellitus Associated with Sirolimus Use in Renal Transplant Recipients

YILMAZ V. T., KOÇAK H., Dinckan A., ÇETİNKAYA R.

EURASIAN JOURNAL OF MEDICINE , cilt.47, sa.3, ss.213-215, 2015 (ESCI) Sürdürülebilir Kalkınma

24. FGF-23, alpha-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients

YILMAZ V. T., ÖZDEM S., DÖNMEZ L., ÇETİNKAYA R., SÜLEYMANLAR G., ERSOY F. F.

EURASIAN JOURNAL OF MEDICINE , cilt.47, sa.2, ss.115-125, 2015 (ESCI)

25. FGF 23 Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients

YILMAZ V. T., ÖZDEM S., DÖNMEZ L., ÇETİNKAYA R., SÜLEYMANLAR G., ERSOY F. F.

Eurasian J Med , cilt.47, 2015 (Scopus)

26. Comparison of Calcineurin Inhibitors with M-Tor Inhibitors in Renal Transplant Patients

YILMAZ V. T., KOÇAK H., DİNÇKAN A., ÇETİNKAYA R., ERSOY F. F., SÜLEYMANLAR G.

Akdeniz Medical Journal , cilt.1, ss.50-57, 2015 (Hakemli Dergi)

27. Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis

YILMAZ V. T., DİNÇER D., Avci A. B., ÇETİNKAYA R.

EURASIAN JOURNAL OF MEDICINE , cilt.47, sa.1, ss.21-25, 2015 (ESCI)

28. Kemik Sağlığı ve Renal Replasman Tedavileri: En İyisi Hangisi?

YILMAZ V. T., ÖZDEM S., DÖNMEZ L., ÇETİNKAYA R., SÜLEYMANLAR G., ERSOY F. F.

Akdeniz Tıp Dergisi \ Akdeniz Medical Journal , cilt.1, sa.1, ss.25-42, 2015 (Hakemli Dergi)

29. Bone Health and Renal Replacement Therapies

YILMAZ V. T., ÖZDEM S., DÖNMEZ L., ÇETİNKAYA R., SÜLEYMANLAR G., ERSOY F. F.

Akdeniz Medical Journal , 2015 (Hakemli Dergi)

30. Obez Kadın Hastalarda Plazma Homosistein Seviyeleri Homosistein ve Obezite

Yılmaz V. T., ÇOBAN E., Avcı A. B., Yılmaz F., Çetinkaya R.

Türk Nefroloji Diyaliz ve Transplantasyon Dergisi , cilt.23, sa.2, ss.91-94, 2014 (Hakemli Dergi) Sürdürülebilir Kalkınma

31. Levels of plasma homocyesteine in obese women subjects Homocysteine and Obesity.

YILMAZ V. T., ÇOBAN E., AVCI A. B., Yılmaz F., ÇETİNKAYA R.

TÜRK NEFROLOJİ DİYALİZ VE TRANSPLANTASYON DERGİSİ , cilt.23, ss.91-94, 2014 (Scopus) Sürdürülebilir Kalkınma

32. Tumor Lysis Syndrome

Çetinkaya R., YILMAZ V. T.

Türkiye Klinikleri J Nephrol Special Topics , sa.1, ss.78-85, 2014 (Hakemli Dergi)

33. Levels Of Plasma Homocysteıne In Obese Women Subjects

YILMAZ V. T., ÇOBAN E., AVCI A. B., Yılmaz F., ÇETİNKAYA R.

Turkish Nephrology, Dialysis And Transplantation Journal. , cilt.23, ss.91-94, 2014 (Scopus)

34. The relation of osteoprotegerin levels with some cardiac parameters in patients with chronic renal failure

ÖZDEM S., ÖZDEM S. S., UZUN G., YILMAZ V. T., ERSOY F. F.

Biochimica Clinica 2013,vol.37. SS , 2013 (Hakemli Dergi)

35. HDL and LDL subfractions in chronic renal failure patients

ÖZDEM S., Doğan S., Aslan M., Uzun G., YILMAZ V. T., ERSOY F. F.

Biochimica Clinica , 2013 (Hakemli Dergi)

36. Full Dose Cyclosporine Versus Low Dose Takrolimus as Maintenance Immunosuppression in Renal Transplant Recipients with Posttransplant Diabetes Mellitus

YILMAZ V. T.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , sa.2, ss.161-166, 2012 (Hakemli Dergi) Sürdürülebilir Kalkınma

37. Is Sirolimus-Tacrolimus Combination Superior to Sirolimus-Cyclosporine Combination in Patients with Renal Transplantation During Early Post-Transplantation Stage?

YILMAZ V. T.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , sa.1, ss.45-53, 2012 (Hakemli Dergi)

38. Is the Type of Pancreas Transplantation and Exocrine Anastomosis Method Important for Successful Pancreas Transplantation? Experience of Akdeniz University Hospital

YILMAZ V. T.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , sa.1, ss.78-83, 2012 (Hakemli Dergi)

39. Milk alkali syndrome with acute renal failure requiring hemodialysis treatment

YILMAZ V. T., Alkan E., AVCI A. B., SÜLEYMANLAR İ., SÜLEYMANLAR G.

Ege Tıp Dergisi , cilt.50, ss.61-64, 2011 (Hakemli Dergi)

40. Successful Renal Transplantation in a Patient with Behcet Disease and Hodgkin Lymphoma in Remission

YILMAZ V. T.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , sa.2, ss.195-199, 2011 (Hakemli Dergi)

41. Milk alkali syndrome with acute renal failure requiring hemodialysis treatment

YILMAZ V. T.

Ege Journal of Medicine , sa.1, ss.61-64, 2011 (Hakemli Dergi)

42. Renal Transplantasyonda İdame İmmunosupressif Tedavi: Genel Yaklaşımlar ve Akdeniz Universitesi Deneyimi

YILMAZ V. T.

Turkiye Klinikleri J Nephrol-Special Topics , sa.2, ss.18-34, 2010 (Hakemli Dergi)

43. RENAL TRANSPLANTASYONDA İDAME İMMUNSUPRESİF TEDAVİ: GENEL YAKLAŞIMLAR VE AKDENİZ ÜNİVERSİTESİ DENEYİMİ

YILMAZ V. T., GURKAN A., SÜLEYMANLAR İ., DINCKAN A., KOÇAK H., ERSOY F., et al.

TÜRKİYE KLİNİKLERİ NEFROLOJİ ÖZEL DERGİSİ , ss.23-26, 2010 (Hakemli Dergi)